Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection
- PMID: 2649286
- PMCID: PMC1542110
Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection
Abstract
Peripheral blood mononuclear cells, PBMC, from 64 HIV-1-infected patients were tested for natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) functions against HIV-1-infected U937 clone 2 cells. The ADCC function was tested both with serum and effector cells from the same patient, with an HIV-1 antibody positive serum and with rabbit IgG antibodies against beta 2-microglobulin expressed on the virus-infected target cells. NK and ADCC functions were often found to be suppressed in HIV-1-infected individuals regardless of the severity of HIV-1 infection. The fact that impaired effector cell functions could be detected even in asymptomatic carriers, suggests that profound changes in cellular immunity may be present at an early stage of HIV-1 infection.
Similar articles
-
Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.J Immunol. 1987 Jul 1;139(1):55-60. J Immunol. 1987. PMID: 3584988
-
Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.J Immunol. 1990 May 1;144(9):3375-84. J Immunol. 1990. PMID: 2329275
-
Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.J Immunol. 1987 Oct 1;139(7):2263-7. J Immunol. 1987. PMID: 3498755
-
Anti-HIV-1 ADCC: clinical and therapeutic implications.Biotechnol Ther. 1991;2(1-2):147-57. Biotechnol Ther. 1991. PMID: 1845118 Review.
-
The role of HIV-specific antibody-dependent cellular cytotoxicity in HIV prevention and the influence of the HIV-1 Vpu protein.AIDS. 2015 Jan 14;29(2):137-44. doi: 10.1097/QAD.0000000000000523. AIDS. 2015. PMID: 25396265 Review.
Cited by
-
The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.Clin Exp Immunol. 2003 Dec;134(3):367-77. doi: 10.1111/j.1365-2249.2003.02292.x. Clin Exp Immunol. 2003. PMID: 14632739 Free PMC article. Review. No abstract available.
-
Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates.J Virol. 1989 Aug;63(8):3376-81. doi: 10.1128/JVI.63.8.3376-3381.1989. J Virol. 1989. PMID: 2746734 Free PMC article.
-
Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines.J Immunol. 2009 Mar 15;182(6):3718-27. doi: 10.4049/jimmunol.0803115. J Immunol. 2009. PMID: 19265150 Free PMC article.
-
Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.J Immunol. 2007 Sep 1;179(5):3362-70. doi: 10.4049/jimmunol.179.5.3362. J Immunol. 2007. PMID: 17709553 Free PMC article.
-
Altered coexpression of lectin-like receptors CD94 and CD161 on NK and T cells in HIV patients.J Clin Immunol. 2004 May;24(3):281-6. doi: 10.1023/B:JOCI.0000025449.16468.6f. J Clin Immunol. 2004. PMID: 15114058
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials